Form D · Biotechnology

AnPac Bio-Medical Science Co., Ltd.

Lishui, F4 · CIK 0001786511

Offering snapshot reported Jun 13, 2022 · SEC filing

Reported sold
$1.5M
Offering amount: $1.5M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 27, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 13, 2022Initial$1,500,000No comparison1SEC filing
Jun 13, 2022Initial$1,500,000No comparison1SEC filing
May 27, 2022Initial$1,400,000No comparison1SEC filing
Aug 24, 2020Initial$265,000No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-448923
Total proceeds received from private offering of ADSs and prefunded ADSs warrants.

Source: Form D, filed Jun 13, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Aidong Chen Director, Executive
Yu Chris Director, Executive
Weidong Dai Executive
Xuedong Du Executive
Xue Dong Du Executive
Jiefeng Gu Executive
Feng Guo Director
Sheng Liu Director
Ren Luo Director
Jianhua Shao Director
Jinqiu Tang Executive
Edward Tang Executive
Pu Xing Director
Chang Yu Director, Executive
Lin Yu Director
He Yu Executive
Chris Chang Yu Director, Executive
Sarah Yu Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
801 Bixing Street, Bihu County.
Lishui, F4, 323006